Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Maruff

Showing results (291-300 of 438) with videos related to

Pageof 44
Sort By:
Journal of Alzheimer'S Disease : JAD|January 11, 2013
Decline in cognitive function over 18 months in healthy older adults with high amyloid-βKathryn A Ellis, Yen Ying Lim, Karra Harrington, et al.
BMC Bioinformatics|December 19, 2014
Genetic algorithm with logistic regression for prediction of progression to Alzheimer's diseasePiers Johnson, Luke Vandewater, William Wilson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2022
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's diseaseRoos J Jutten, Kathryn V Papp, Suzanne Hendrix, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortiumAlden L Gross, Jason J Hassenstab, Sterling C Johnson, et al.
Alzheimer'S Research & Therapy|April 26, 2026
Genetic drivers of progression in Alzheimer's disease are distinct from disease riskCeleste E Cohen, Shane Fernandez, Umran Yaman, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2022
A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous ApproachRoos J Jutten, Louisa Thompson, Sietske A M Sikkes, et al.
Frontiers in Aging Neuroscience|December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle StudySamantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2023
The relationship between objective physical activity and change in cognitive functionKelsey R Sewell, Stephanie R Rainey-Smith, Jeremiah Peiffer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2014
Aβ and cognitive change: examining the preclinical and prodromal stages of Alzheimer's diseaseYen Ying Lim, Paul Maruff, Robert H Pietrzak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 23, 2016
Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohortEster Cerin, Stephanie R Rainey-Smith, David Ames, et al.
Pageof 44

Showing results (291-300 of 438) with videos related to

Sort By:
Pageof 44
Journal of Alzheimer'S Disease : JAD|January 11, 2013
Decline in cognitive function over 18 months in healthy older adults with high amyloid-βKathryn A Ellis, Yen Ying Lim, Karra Harrington, et al.
BMC Bioinformatics|December 19, 2014
Genetic algorithm with logistic regression for prediction of progression to Alzheimer's diseasePiers Johnson, Luke Vandewater, William Wilson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 10, 2022
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's diseaseRoos J Jutten, Kathryn V Papp, Suzanne Hendrix, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortiumAlden L Gross, Jason J Hassenstab, Sterling C Johnson, et al.
Alzheimer'S Research & Therapy|April 26, 2026
Genetic drivers of progression in Alzheimer's disease are distinct from disease riskCeleste E Cohen, Shane Fernandez, Umran Yaman, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2022
A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous ApproachRoos J Jutten, Louisa Thompson, Sietske A M Sikkes, et al.
Frontiers in Aging Neuroscience|December 6, 2021
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle StudySamantha L Gardener, Stephanie R Rainey-Smith, Victor L Villemagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 19, 2023
The relationship between objective physical activity and change in cognitive functionKelsey R Sewell, Stephanie R Rainey-Smith, Jeremiah Peiffer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 5, 2014
Aβ and cognitive change: examining the preclinical and prodromal stages of Alzheimer's diseaseYen Ying Lim, Paul Maruff, Robert H Pietrzak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 23, 2016
Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohortEster Cerin, Stephanie R Rainey-Smith, David Ames, et al.
Pageof 44